158 related articles for article (PubMed ID: 18622581)
1. Malignant prolactinoma with craniospinal metastasis in a 12-year-old boy.
Huang AP; Yang SH; Yang CC; Kuo MF; Wu MZ; Tu YK
J Neurooncol; 2008 Oct; 90(1):41-6. PubMed ID: 18622581
[TBL] [Abstract][Full Text] [Related]
2. A case of prolactin-secreting pituitary carcinoma and its histological findings.
Noda M; Suzuki R; Moriya M; Itokawa H; Asai J; Nagashima G; Fujimoto T
Brain Tumor Pathol; 2004; 21(3):149-54. PubMed ID: 15696977
[TBL] [Abstract][Full Text] [Related]
3. Malignant prolactinoma with multiple bone and pulmonary metastases. Case report.
Lamas C; Núñez R; García-Uría J; Salas C; Saucedo G; Estrada J; Parajón A; Lucas T
J Neurosurg; 2004 Aug; 101(1 Suppl):116-21. PubMed ID: 16206983
[TBL] [Abstract][Full Text] [Related]
4. Malignant prolactinoma: case report and review of the literature.
Popadić A; Witzmann A; Buchfelder M; Eiter H; Komminoth P
Surg Neurol; 1999 Jan; 51(1):47-54; discussion 54-5. PubMed ID: 9952123
[TBL] [Abstract][Full Text] [Related]
5. Giant, solid, invasive prolactinoma in a prepubescent boy with gynecomastia.
Furtado SV; Saikiran NA; Ghosal N; Hegde AS
Pediatr Neurol; 2010 Jan; 42(1):72-4. PubMed ID: 20004869
[TBL] [Abstract][Full Text] [Related]
6. Evolution of a refractory prolactin-secreting pituitary adenoma into a pituitary carcinoma: report of a challenging case and literature review.
Dai C; Sun B; Guan S; Wang W; Liu H; Li Y; Zhang J; Kang J
BMC Endocr Disord; 2021 Oct; 21(1):217. PubMed ID: 34715828
[TBL] [Abstract][Full Text] [Related]
7. Extremely late development of pituitary carcinoma after surgery and radiotherapy.
Figueiredo EG; Paiva WS; Teixeira MJ
J Neurooncol; 2009 Apr; 92(2):219-22. PubMed ID: 19034384
[TBL] [Abstract][Full Text] [Related]
8. Pituitary carcinoma with fourth ventricle metastasis: treatment by excision and Gamma-knife radiosurgery.
Park KS; Hwang JH; Hwang SK; Kim S; Park SH
Pituitary; 2014 Dec; 17(6):514-8. PubMed ID: 24272034
[TBL] [Abstract][Full Text] [Related]
9. Combined modalities of surgery, radiotherapy, radiosurgery and chemotherapy for invasive pituitary carcinoma.
Tuleasca C; Messerer M; Levivier M; Daniel RT
Ann Endocrinol (Paris); 2018 Apr; 79(2):82-85. PubMed ID: 29525560
[No Abstract] [Full Text] [Related]
10. Prevalence and characteristics of sellar masses in the city of Al Ain, United Arab Emirates: 2010 to 2016.
Aldahmani KM; Sreedharan J; Ismail MM; Philip J; Nair SC; Alfelasi M; Aziz W; Imran SA; Alkaabi J
Ann Saudi Med; 2020; 40(2):105-112. PubMed ID: 32241168
[TBL] [Abstract][Full Text] [Related]
11. Malignant prolactinoma: is metastasis a must? Clinico-pathologic and immunohistochemical study of a case.
Vaishya S; Tondon A
J Neurosurg Sci; 2004 Mar; 48(1):37-41. PubMed ID: 15257264
[TBL] [Abstract][Full Text] [Related]
12. [Indications for surgical treatment of prolactin-secreting pituitary adenomas].
Kalinin PL; Astaf'eva LI; Kadashev BA; Ismailov DB
Zh Vopr Neirokhir Im N N Burdenko; 2017; 81(5):117-124. PubMed ID: 29076475
[TBL] [Abstract][Full Text] [Related]
13. Long-term therapeutic success with multimodal therapy in aggressive prolactinoma.
Iglesias P; Rodríguez Berrocal V; Pian H; Díez JJ
Endocrinol Diabetes Nutr (Engl Ed); 2019; 66(7):464-466. PubMed ID: 30797752
[No Abstract] [Full Text] [Related]
14. Malignant prolactinoma.
Berezin M; Gutman I; Tadmor R; Horowitz A; Findler G
Acta Endocrinol (Copenh); 1992 Nov; 127(5):476-80. PubMed ID: 1471460
[TBL] [Abstract][Full Text] [Related]
15. An unusual association of a sellar gangliocytoma with a prolactinoma.
Serri O; Berthelet F; Bélair M; Vallette S; Asa SL
Pituitary; 2008; 11(1):85-7. PubMed ID: 17440820
[TBL] [Abstract][Full Text] [Related]
16. Pediatric pituitary adenoma.
Tamura T; Tanaka R; Korii K; Okazaki H
Endocr J; 2000 Mar; 47 Suppl():S95-9. PubMed ID: 10890194
[No Abstract] [Full Text] [Related]
17. Case report of sarcoma of the sella caused by postoperative radiotherapy for a prolactin-producing pituitary adenoma.
Kurosaki M; Kambe A; Ishibashi M; Watanabe T; Horie Y
Brain Tumor Pathol; 2014 Jul; 31(3):187-91. PubMed ID: 24446079
[TBL] [Abstract][Full Text] [Related]
18. Metastatic prolactinoma: case report with immunohistochemical assessment for p53 and Ki-67 antigens.
Crusius PS; Forcelini CM; Mallmann AB; Silveira DA; Lersch E; Seibert CA; Crusius MU; Carazzo CA; Crusius CU; Goellner E
Arq Neuropsiquiatr; 2005 Sep; 63(3B):864-9. PubMed ID: 16258673
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy of prolactinoma with a T helper 1 activator adjuvant and autoantigens: a case report.
Hazrati SM; Aghazadeh J; Mohtarami F; Abouzari M; Rashidi A
Neuroimmunomodulation; 2006; 13(4):205-8. PubMed ID: 17337912
[TBL] [Abstract][Full Text] [Related]
20. Retention of dopamine 2 receptor mRNA and absence of the protein in craniospinal and extracranial metastasis of a malignant prolactinoma: a case report.
Winkelmann J; Pagotto U; Theodoropoulou M; Tatsch K; Saeger W; Müller A; Arzberger T; Schaaf L; Schumann EM; Trenkwalder C; Stalla GK
Eur J Endocrinol; 2002 Jan; 146(1):81-8. PubMed ID: 11751072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
